Loading…
Zydus MedTech, a subsidiary of Zydus Lifesciences, has entered a strategic partnership with Brazil-based Braile Biomedica to exclusively commercialize Braile's Transcatheter Aortic Valve Implantation (TAVI) technology in Europe, India, and select markets. The purchase price was not disclosed.
Zydus Lifesciences entered exclusive negotiations to acquire 85.6% of Amplitude Surgical at €6.25 per share, valuing the block at €256.8 million, with a mandatory tender offer for remaining shares.